Name | 1-Phenyl-4-[2-(1H-tetrazol-5-yl)ethyl]piperazine |
---|
Description | Zolertine hydrochloride is an α-adrenoceptor antagonist with a pKi of 6.81 in rat liver (α1B-adrenoceptors) and 6.35 in rabbit liver (α1A-adrenoceptors) membranes[1]. |
---|---|
Related Catalog | |
Target |
α1A-adrenergic receptor:6.35 (pKi, in rabbit liver membrane) α1B-adrenergic receptor:6.81 (pKi, in rat liver membrane) |
In Vitro | 在大鼠的颈动脉和主动脉中,Zolertine hydrochloride 竞争性地抗拮抗了去甲肾上腺素诱导的收缩反应,得到的 pA2 值分别为:WKY 7.48±0.18,SHR 7.43±0.13;以及 WKY 7.57±0.24,SHR 7.40±0.08。在一些血管中,Zolertine hydrochloride 表现为非竞争性拮抗剂,因为 Schild 图的斜率小于 1。Zolertine hydrochloride 的 pKb 估值在肠系膜动脉中为 WKY 6.98±0.16,SHR 6.81±0.18;在尾动脉中为 WKY 5.73±0.11,SHR 5.87±0.25;在兔主动脉中为 6.65±0.09[1]。 与 α1A-肾上腺素受体相比,Zolertine hydrochloride 对 α1D-肾上腺素受体的亲和力更高,而对 α1B-肾上腺素受体的亲和力居中[1]。 |
References |
Molecular Formula | C13H19ClN6 |
---|---|
Molecular Weight | 294.78 |
Exact Mass | 258.15900 |
PSA | 60.94000 |
LogP | 0.56730 |